Liftstream is an executive search recruitment company in the life sciences sector
5 Reasons Big-Company Execs are Defecting to Biotech
Author: Karl Simpson
Posted in Executive Appointments
Tagged Adaptimmune, Avalon, Bay Area Cluster, Boston Biotech, Briggs Morrison, Doug Williams, EY Beyond Borders 2015, Forma Therapeutics, Henri Termeer, John Hohneker, Jose-Carlos Gutierrez, London Biotech, Nasdaq Biotechnology Index, Novartis, Open Innovation, Oxford Biotech, Pascal Soriot, Rafael Amado, San Diego, Syndax, Synlogic, Versant Ventures
Leave a comment
Gene Therapy Start-up AAVLife raises $12m
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged AAVLife, Amber Salzman, biotech cluster, Dr Helene Puccio, Dr Pierre Bougneres, Dr Ronald Crystal, France, Friedreich’s Ataxia, funding, gene-deleting therapy, GSK, INSERM, Nature Medicine, Paris, Pierre Aubourg, Versant Ventures
Leave a comment
Audentes Therapeutics raises $30 in series A financing
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged 5AM Ventures, Audentes Therapeutics, Bluebird bio, Chiesi, Gene therapy, Glybera, Jonathan Silverstein, Kush Parmar, Matthew R. Patterson, OrbiMed Advisors, Orphan drugs, Pompe Disease, rare diseases, series A funding, Thomas J. Schuetz, Thomas Woiwode, uniQure, venture capital, Versant Ventures, x-linked myotubular myopathy, XLMTM
Leave a comment
Pharma marries VCs to give birth to Biotechs
Authored by Karl Simpson
Posted in M&A Finance and Funding, Pharmaceutical business
Tagged Amgen, Atlas Ventures, Avalon Ventures, biotech, Bruce Booth, celgene, collaborative business models, Francesco De Rubertis, Fund IX, GSK, Index Ventures, J&J, Johnson & Johnson, Kevin Johnson, Large Pharma, LSD, Nimbus Discovery, Novartis, Pangenetics, Paul Stoffels, pharma, Quanticel, R&D, Sanofi, Shire HGT, SR One, Third Rock Ventures, Tibotec, venture capital, Versant Ventures, Warp Drive Bio
Leave a comment